151 related articles for article (PubMed ID: 33649780)
21. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.
Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X
J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of far upstream element-binding protein 1 (FUBP1) promotes tumor proliferation and unfavorable prognosis in tongue squamous cell carcinoma.
Chen Y; Liu J; Geng N; Feng C
Int J Biol Markers; 2020 Jun; 35(2):56-65. PubMed ID: 32339054
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA‑133b targets TGFβ receptor I to inhibit TGF‑β‑induced epithelial‑to‑mesenchymal transition and metastasis by suppressing the TGF‑β/SMAD pathway in breast cancer.
Wang S; Huang M; Wang Z; Wang W; Zhang Z; Qu S; Liu C
Int J Oncol; 2019 Nov; 55(5):1097-1109. PubMed ID: 31545407
[TBL] [Abstract][Full Text] [Related]
24. LncRNA LINC00857 strengthens the malignancy behaviors of pancreatic adenocarcinoma cells by serving as a competing endogenous RNA for miR-340-5p to upregulate TGFA expression.
Li T; Zhao H; Zhou H; Geng T
PLoS One; 2021; 16(3):e0247817. PubMed ID: 33661995
[TBL] [Abstract][Full Text] [Related]
25. ARHGAP25 Inhibits Pancreatic Adenocarcinoma Growth by Suppressing Glycolysis via AKT/mTOR Pathway.
Huang WK; Chen Y; Su H; Chen TY; Gao J; Liu Y; Yeh CN; Li S
Int J Biol Sci; 2021; 17(7):1808-1820. PubMed ID: 33994864
[TBL] [Abstract][Full Text] [Related]
26. HLTF suppresses the migration and invasion of colorectal cancer cells via TGF‑β/SMAD signaling in vitro.
Liu L; Liu H; Zhou Y; He J; Liu Q; Wang J; Zeng M; Yuan D; Tan F; Zhou Y; Pei H; Zhu H
Int J Oncol; 2018 Dec; 53(6):2780-2788. PubMed ID: 30320371
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA‑181a promotes epithelial‑mesenchymal transition in esophageal squamous cell carcinoma via the TGF‑β/Smad pathway.
Xu R; Zhou XM; Li YS; Ren L; He XR
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760133
[TBL] [Abstract][Full Text] [Related]
28.
Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
Front Immunol; 2022; 13():805311. PubMed ID: 35154122
[TBL] [Abstract][Full Text] [Related]
29. HOXD9‑induced SCNN1A upregulation promotes pancreatic cancer cell proliferation, migration and predicts prognosis by regulating epithelial‑mesenchymal transformation.
Chang J; Hu X; Nan J; Zhang X; Jin X
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34558641
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological features, prognostic significance, and associated tumor cell functions of family with sequence similarity 111 member B in pancreatic adenocarcinoma.
Gong Q; Dong Q; Zhong B; Zhang T; Cao D; Zhang Y; Ma D; Cai X; Li Z
J Clin Lab Anal; 2022 Dec; 36(12):e24784. PubMed ID: 36408702
[TBL] [Abstract][Full Text] [Related]
31. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.
Xu H; Mao J; Yang X; Chen F; Song Z; Fei J; Chen W; Zhong Z; Wang X
Mol Med Rep; 2020 Nov; 22(5):4329-4339. PubMed ID: 33000197
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of CBX3 in Pancreatic Adenocarcinoma Promotes Cell Cycle Transition-Associated Tumor Progression.
Chen LY; Cheng CS; Qu C; Wang P; Chen H; Meng ZQ; Chen Z
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29903985
[TBL] [Abstract][Full Text] [Related]
33. Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cells.
Yoshida J; Ishikawa T; Endo Y; Matsumura S; Ota T; Mizushima K; Hirai Y; Oka K; Okayama T; Sakamoto N; Inoue K; Kamada K; Uchiyama K; Takagi T; Naito Y; Itoh Y
Oncol Rep; 2020 Jul; 44(1):371-381. PubMed ID: 32627027
[TBL] [Abstract][Full Text] [Related]
34. NELFE promoted pancreatic cancer metastasis and the epithelial‑to‑mesenchymal transition by decreasing the stabilization of NDRG2 mRNA.
Han L; Zan Y; Huang C; Zhang S
Int J Oncol; 2019 Dec; 55(6):1313-1323. PubMed ID: 31638184
[TBL] [Abstract][Full Text] [Related]
35. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of FUBP1 is associated with human cervical carcinoma development and prognosis.
Ma C; Huang Z; Wu Z; Di C; Lin X; Huang M; Hong H; Yin H
Life Sci; 2021 Mar; 269():119098. PubMed ID: 33476628
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
[TBL] [Abstract][Full Text] [Related]
38. 14-3-3σ downregulation sensitizes pancreatic cancer to carbon ions by suppressing the homologous recombination repair pathway.
Wang D; Luo H; Chen Y; Ou Y; Dong M; Chen J; Liu R; Wang X; Zhang Q
Aging (Albany NY); 2024 Jun; 16(11):9727-9752. PubMed ID: 38843383
[TBL] [Abstract][Full Text] [Related]
39. SQLE, A Key Enzyme in Cholesterol Metabolism, Correlates With Tumor Immune Infiltration and Immunotherapy Outcome of Pancreatic Adenocarcinoma.
You W; Ke J; Chen Y; Cai Z; Huang ZP; Hu P; Wu X
Front Immunol; 2022; 13():864244. PubMed ID: 35720314
[TBL] [Abstract][Full Text] [Related]
40. TGF-β1/Smad signaling pathway regulates epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: in vitro and clinical analyses of cell lines and nomadic Kazakh patients from northwest Xinjiang, China.
Pang L; Li Q; Wei C; Zou H; Li S; Cao W; He J; Zhou Y; Ju X; Lan J; Wei Y; Wang C; Zhao W; Hu J; Jia W; Qi Y; Liu F; Jiang J; Li L; Zhao J; Liang W; Xie J; Li F
PLoS One; 2014; 9(12):e112300. PubMed ID: 25464508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
